Regeneron Pharmaceuticals Inc (REGN)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$604.21

Buy

$610.00

arrow-up$2.01 (+0.33%)

Prices updated at 19 Jun 2026, 00:51 EDT

Prices minimum 15 mins delay

Prices in USD

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age ...

NASDAQ

1.91%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

our Investment Fees and Charges.

	$616.24 - $598.19
	$821.11 - $506.38
	0.59
	63,945.52m
	14.89
	-
	2,609,258
	2.03
	959,765.79
	0.06
	139.42m
	US75886F1075
	40.96
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.